title: [Thoracoscopic right middle lobectomy and adjuvant chemotherapy for pulmonary mucosal associated lymphoid tissue (MALT) lymphoma; report of a case].
abstract: A 37 year-old man with preoperative diagnosis of pulmonary mucosal associated lymphoid tissue (MALT) lymphoma underwent right middle lobectomy thoracoscopically followed by adjuvant chemotherapy since 18 days after the operation. The patient is free from recurrence 6 months after the operation. Pulmonary MALT lymphoma is rare and its treatment is controversial. This patient underwent surgical treatment and adjuvant chemotherapy because the tumor is limited to right middle lobe. Thoracoscopic lobectomy is less invasive and it was possible to perform adjuvant chemotherapy soon after the operation.
authors.affiliation: Department of Surgery, Kurashiki Central Hospital, Kurashiki, Japan.
authors.forename: Shusaku
authors.initials: S
authors.lastname: Homma
authors.forename: Kazumichi
authors.initials: K
authors.lastname: Yamamoto
authors.forename: Mitsuhiro
authors.initials: M
authors.lastname: Ueda
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Miyamoto
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000628:therapy*; D008297:Male; D011013:Pneumonectomy / Q000379:methods*; D000069283:Rituximab; D013906:Thoracoscopy
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab